TGFBI p.H626R Mutation in a Chinese Family with Lattice Corneal Dystrophy: A Short Report and Literature Review.

Genet Test Mol BiomarkersAug 11, 2026 (epub)

Xuan Lu, Ke Zhang, Rubing Liu et al.

✦ AI-curated · Sources linked

Case in brief

A three-generation Chinese family with lattice corneal dystrophy underwent ophthalmic assessment and genetic testing. Sequencing identified a heterozygous TGFBI c.1877A>G (p.His626Arg) mutation in affected family members. At advanced disease stages, all patients underwent penetrating keratoplasty, after which visual acuity improved. A review of previously reported H626R-associated cases described recurrent corneal erosions, asymmetrical progression, and thick lattice lines extending toward the corneal periphery.

What made this case unusual

The H626R-associated phenotype was described as including thick lattice lines extending toward the corneal periphery and asymmetrical progression, alongside recurrent corneal erosions.

Diagnostic / clinical pearl

In a family with lattice corneal dystrophy, genetic testing can identify TGFBI p.His626Arg; the reported phenotype includes peripheral extension of thick lattice lines and asymmetrical progression.

Source

Published in Genet Test Mol Biomarkers. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.